These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 3476689

  • 1. Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.
    Amadori S, Ceci A, Comelli A, Madon E, Masera G, Nespoli L, Paolucci G, Zanesco L, Covelli A, Mandelli F.
    J Clin Oncol; 1987 Sep; 5(9):1356-63. PubMed ID: 3476689
    [Abstract] [Full Text] [Related]

  • 2. High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study.
    Ravindranath Y, Steuber CP, Krischer J, Civin CI, Ducore J, Vega R, Pitel P, Inoue S, Bleher E, Sexauer C.
    J Clin Oncol; 1991 Apr; 9(4):572-80. PubMed ID: 2066754
    [Abstract] [Full Text] [Related]

  • 3. Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital.
    Hurwitz CA, Krance R, Schell MJ, Santana VM, Brenner MK, Ribeirio R, Roberts WM, Mahmoud H, Belt J, Crom W.
    Leukemia; 1992 Apr; 6 Suppl 2():39-43. PubMed ID: 1374492
    [Abstract] [Full Text] [Related]

  • 4. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
    Hansen OP, Pedersen-Bjergaard J, Ellegaard J, Brincker H, Boesen AM, Christensen BE, Drivsholm A, Hippe E, Jans H, Jensen KB.
    Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
    [Abstract] [Full Text] [Related]

  • 5. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
    Amadori S, Testi AM, Aricò M, Comelli A, Giuliano M, Madon E, Masera G, Rondelli R, Zanesco L, Mandelli F.
    J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K, Ritter J, Schellong G, Beck JD, Kabisch H, Lampert F, Creutzig U.
    Klin Padiatr; 1992 Jun; 204(4):253-7. PubMed ID: 1518261
    [Abstract] [Full Text] [Related]

  • 7. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
    Maluf PT, Odone Filho V, Cristofani LM, Britto JL, Almeida MT, Pontes E, Maksoud JG, Manissadjian A.
    J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717
    [Abstract] [Full Text] [Related]

  • 8. Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia.
    Loeb DM, Bowers DC, Civin CI, Friedman AD.
    Med Pediatr Oncol; 2001 Oct; 37(4):365-71. PubMed ID: 11568900
    [Abstract] [Full Text] [Related]

  • 9. [Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group].
    Creutzig U, Ritter J, Heyen P, Berthold F, Henze G, Kabisch H, Lampert F, Niethammer D, Riehm H, Schellong G.
    Klin Padiatr; 1992 Oct; 204(4):236-45. PubMed ID: 1518259
    [Abstract] [Full Text] [Related]

  • 10. Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.
    Crews KR, Gandhi V, Srivastava DK, Razzouk BI, Tong X, Behm FG, Plunkett W, Raimondi SC, Pui CH, Rubnitz JE, Stewart CF, Ribeiro RC.
    J Clin Oncol; 2002 Oct 15; 20(20):4217-24. PubMed ID: 12377965
    [Abstract] [Full Text] [Related]

  • 11. [Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children].
    Ortega Aramburu JJ, Olivé Oliveras T, Javier Manchón G, Bastida Vila P, Sánchez C, Giralt López J.
    Sangre (Barc); 1991 Feb 15; 36(1):7-14. PubMed ID: 1853274
    [Abstract] [Full Text] [Related]

  • 12. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F, Fernández-Barbieri MA, Santarelli MT, Matus-Ridley M, Rosso A, Negri-Aranguren P, Cerutti I, Gomel M, Kvicala R.
    Semin Oncol; 1993 Dec 15; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [Abstract] [Full Text] [Related]

  • 13. Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze.
    Grier HE, Gelber RD, Link MP, Camitta BP, Clavell LA, Weistein HJ.
    Leukemia; 1992 Dec 15; 6 Suppl 2():48-51. PubMed ID: 1374493
    [Abstract] [Full Text] [Related]

  • 14. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.
    Büchner T, Urbanitz D, Hiddemann W, Rühl H, Ludwig WD, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G.
    J Clin Oncol; 1985 Dec 15; 3(12):1583-9. PubMed ID: 3906048
    [Abstract] [Full Text] [Related]

  • 15. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
    Löwenberg B, Suciu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R, Dekker AW, Berneman ZN, Thyss A, van der Lelie J, Sonneveld P, Visani G, Fillet G, Hayat M, Hagemeijer A, Solbu G, Zittoun R.
    J Clin Oncol; 1998 Mar 15; 16(3):872-81. PubMed ID: 9508168
    [Abstract] [Full Text] [Related]

  • 16. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.
    Kalwinsky D, Mirro J, Schell M, Behm F, Mason C, Dahl GV.
    J Clin Oncol; 1988 Jul 15; 6(7):1134-43. PubMed ID: 3292713
    [Abstract] [Full Text] [Related]

  • 17. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S, Sakamaki H, Ohtake S, Emi N, Yagasaki F, Mitani K, Matsuda S, Kishimoto Y, Miyazaki Y, Asou N, Matsushima T, Takahashi M, Ogawa Y, Honda S, Ohno R, Japan Adult Leukemia Study Group AML 97 Study.
    Cancer; 2005 Dec 15; 104(12):2726-34. PubMed ID: 16284985
    [Abstract] [Full Text] [Related]

  • 18. Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.
    Amadori S, Mandelli F, Ceci A, Comelli A, Madon E, Masera G, Nespoli L, Paolucci G, Zanesco L, Defazio D.
    Bone Marrow Transplant; 1989 Jan 15; 4 Suppl 1():114-5. PubMed ID: 2653484
    [No Abstract] [Full Text] [Related]

  • 19. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y, Chang M, Steuber CP, Becton D, Dahl G, Civin C, Camitta B, Carroll A, Raimondi SC, Weinstein HJ, Pediatric Oncology Group.
    Leukemia; 2005 Dec 15; 19(12):2101-16. PubMed ID: 16136167
    [Abstract] [Full Text] [Related]

  • 20. Etoposide in remission induction of adult acute myeloid leukemia.
    Leoni F, Ciolli S, Patriarchi S, Morfini M, Rossi Ferrini P.
    Acta Haematol; 1990 Dec 15; 83(2):82-5. PubMed ID: 2106200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.